Clinical trial
Combination Chemotherapy Plus Amifostine in Treating Children With Malignant…
NCT00003811 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00003811 |
|---|---|
| Title | Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors |
| Official title | High-Dose Cisplatin, Etoposide and Bleomycin (HD-PEB) Combined With Amifostine in Children With High-Risk Malignant Germ Cell Tumors - A POG Pilot Study |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Childhood Germ Cell Tumor, Drug/Agent Toxicity by Tissue/Organ, Extragonadal Germ Cell Tumor, Ovarian Cancer |
| Intervention type | Biological, Drug, Procedure |
| Interventions | bleomycin sulfate, amifostine trihydrate, cisplatin, etoposide, conventional surgery |
| Enrollment | 27 |
| Start date | Apr 1, 2000 |
| Primary completion | Oct 1, 2004 |
| Completion | Sep 1, 2007 |
| First posted | Dec 10, 2003 |
| Last update posted | Jul 4, 2013 |
| Countries | Australia, Canada, Netherlands, Puerto Rico, Switzerland, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: